StonvexLoading…
StonvexStonvexStonvexCore line items from META's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $200.97B | $164.50B | $134.90B | $116.61B |
Operating Income | $83.28B | $69.38B | $46.75B | $28.94B |
Net Income | $60.46B | $62.36B | $39.10B | $23.20B |
EPS (Diluted) | $23.49 | $23.86 | $14.87 | $8.59 |
Total Assets | $366.02B | $276.05B | $229.62B | $185.73B |
Total Liabilities | $148.78B | $93.42B | $76.45B | $60.01B |
Cash & Equivalents | $35.87B | $43.89B | $41.86B | $14.68B |
Free Cash Flow OCF − CapEx | $46.11B | $54.07B | $44.07B | $19.29B |
Shares Outstanding | 2.57B | 2.61B | 2.63B | 2.70B |